middle.news
INOVIQ Advances Cancer Diagnostics with 94% Accurate Ovarian Test and Therapeutic Breakthroughs
6:28pm on Sunday 1st of June, 2025 AEST
•
Biotechnology
Read Story
INOVIQ Advances Cancer Diagnostics with 94% Accurate Ovarian Test and Therapeutic Breakthroughs
6:28pm on Sunday 1st of June, 2025 AEST
Key Points
EXO-NET customer base expands to 41 globally
Ovarian cancer screening test achieves over 94% accuracy
CAR-NK-exosome therapeutic shows effective breast cancer cell killing in vitro
neuCA15-3 breast cancer monitoring test confirms disease specificity
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Inoviq (ASX:IIQ)
OPEN ARTICLE